Kiniksa Pharmaceuticals International, plc (KNSA) insider trading
Every open-market stock purchase and sale by Kiniksa Pharmaceuticals International, plc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Michael R Megna (C-suite exec) and 1 other sold $668K in the last 90 days.
- Last insider buy: Baker Bros. Advisors LP (10% owner), $48.6M, 8 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $60.3M (28 sales). Last close $80.47 on Sep 3, 2026.
Recent KNSA insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 3, 2026 | Michael R Megna (C-suite exec) | Sold | $369K |
| Sep 1, 2026 | Sanj K Patel (CEO) | Sold (not open market) | $1.2M |
| Sep 1, 2026 | Sanj K Patel (CEO) | Sold (not open market) | $1.2M |
| Sep 1, 2026 | Michael R Megna (C-suite exec) | Sold (not open market) | $438K |
| Sep 1, 2026 | Mark Ragosa (CFO) | Sold (not open market) | $349K |
| Sep 1, 2026 | John F. Paolini (C-suite exec) | Sold (not open market) | $319K |
| Sep 1, 2026 | Ross Moat (COO) | Sold (not open market) | $318K |
| Sep 1, 2026 | Mark Ragosa (CFO) | Bought (not open market) | — |
| Sep 1, 2026 | Sanj K Patel (CEO) | Bought (not open market) | — |
| Sep 1, 2026 | Mark Ragosa (CFO) | Bought (not open market) | — |
| Sep 1, 2026 | Ross Moat (COO) | Bought (not open market) | — |
| Sep 1, 2026 | Michael R Megna (C-suite exec) | Bought (not open market) | — |
| Sep 1, 2026 | John F. Paolini (C-suite exec) | Bought (not open market) | — |
| Sep 1, 2026 | John F. Paolini (C-suite exec) | Bought (not open market) | — |
| Sep 1, 2026 | Mark Ragosa (CFO) | Bought (not open market) | — |
| Sep 1, 2026 | Ross Moat (COO) | Bought (not open market) | — |
| Sep 1, 2026 | Ross Moat (COO) | Bought (not open market) | — |
| Sep 1, 2026 | Sanj K Patel (CEO) | Bought (not open market) | — |
| Sep 1, 2026 | Michael R Megna (C-suite exec) | Bought (not open market) | — |
| Sep 1, 2026 | Michael R Megna (C-suite exec) | Bought (not open market) | — |
| Sep 1, 2026 | Sanj K Patel (CEO) | Bought (not open market) | — |
| Sep 1, 2026 | Ross Moat (COO) | Bought (not open market) | — |
| Sep 1, 2026 | John F. Paolini (C-suite exec) | Bought (not open market) | — |
| Sep 1, 2026 | Mark Ragosa (CFO) | Bought (not open market) | — |
| Sep 1, 2026 | Sanj K Patel (CEO) | Bought (not open market) | — |
Who's trading KNSA
- Michael R Megna, C-suite exec: sold $2.6M (4 sales), last Sep 3, 2026
- Sanj K Patel, CEO: sold $39.4M (12 sales), last Sep 1, 2026
- Mark Ragosa, CFO: sold $5.6M (8 sales), last Sep 1, 2026
- Ross Moat, C-suite exec: sold $195K (2 sales), last Sep 1, 2026
- John F. Paolini, C-suite exec: sold $8M (6 sales), last Sep 1, 2026
- Barry D Quart, Insider: sold $2.7M (8 sales), last Aug 19, 2026
- Richard S Levy, Insider: other filings, last Aug 1, 2026
- G Bradley Cole, Insider: sold $299K (1 sale), last Jul 29, 2026
- Dhiraj H Malkani, C-suite exec: other filings, last Jul 1, 2026
- Baker Bros. Advisors LP, Insider: other filings, last May 29, 2026
- Thomas Malley, Insider: other filings, last May 29, 2026
- Tracey L McCain, Insider: other filings, last May 29, 2026
- Kimberly J Popovits, Insider: other filings, last May 29, 2026
- Eben Tessari, COO: sold $1.5M (6 sales), last Apr 7, 2026
Get free alerts when an insider at Kiniksa Pharmaceuticals International, plc files a new trade →